Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Treasury Shares: 2024

Historic Treasury Shares for Janux Therapeutics (JANX) over the last 1 years, with Dec 2024 value amounting to $341,847.

  • Janux Therapeutics' Treasury Shares rose 768.23% to $699,467 in Q3 2025 from the same period last year, while for Sep 2025 it was $699,467, marking a year-over-year increase of 768.23%. This contributed to the annual value of $341,847 for FY2024, which is N/A change from last year.
  • Janux Therapeutics' Treasury Shares amounted to $341,847 in FY2024.
  • Over the past 5 years, Janux Therapeutics' Treasury Shares peaked at $341,847 during FY2024, and registered a low of $341,847 during FY2024.
  • For the 1-year period, Janux Therapeutics' Treasury Shares averaged around $341,847, with its median value being $341,847 (2024).